Stay updated on Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the expected content. This makes the record inaccessible and prevents viewing the trial details.
    Difference
    20%
    Check dated 2026-09-22T23:54:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0 instead of v3.6.6, indicating a software update to the Study Details page. There are no observed changes to the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-15T23:55:18.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6 instead of v3.6.5. This reflects a minor maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-09-01T20:21:54.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4; this indicates a new version of the page, likely reflecting minor updates rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T21:56:19.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 label was added, replacing Revision: v3.6.3. This indicates a backend/content-management update rather than a change to the study data on the page.
    Difference
    0.0%
    Check dated 2026-07-28T15:40:23.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    A new site revision label (Revision: v3.6.3) appears, replacing the previous v3.6.0. This indicates a recent update to the page's underlying software or formatting.
    Difference
    0.0%
    Check dated 2026-06-30T00:40:32.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Recurrent/ Metastatic Endometrial Cancer Clinical Trial page.